Rafferty Asset Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.83M Sell
123,854
-21,167
-15% -$313K 0.01% 621
2025
Q1
$2.6M Sell
145,021
-31,404
-18% -$563K 0.01% 506
2024
Q4
$3.07M Buy
176,425
+84,654
+92% +$1.47M 0.01% 517
2024
Q3
$1.28M Sell
91,771
-90,521
-50% -$1.27M ﹤0.01% 743
2024
Q2
$1.5M Sell
182,292
-412,940
-69% -$3.39M 0.01% 719
2024
Q1
$4.59M Buy
595,232
+166,071
+39% +$1.28M 0.02% 491
2023
Q4
$3.86M Buy
429,161
+67,168
+19% +$604K 0.02% 501
2023
Q3
$3.24M Sell
361,993
-136,259
-27% -$1.22M 0.02% 484
2023
Q2
$7.65M Buy
498,252
+171,782
+53% +$2.64M 0.04% 299
2023
Q1
$7.34M Buy
326,470
+7,016
+2% +$158K 0.05% 273
2022
Q4
$6.72M Buy
319,454
+113,687
+55% +$2.39M 0.06% 311
2022
Q3
$5.07M Buy
205,767
+72,542
+54% +$1.79M 0.05% 335
2022
Q2
$3.23M Sell
133,225
-28,018
-17% -$679K 0.03% 374
2022
Q1
$4.16M Sell
161,243
-12,043
-7% -$310K 0.02% 422
2021
Q4
$5.38M Buy
173,286
+73,364
+73% +$2.28M 0.03% 364
2021
Q3
$2.42M Sell
99,922
-34,739
-26% -$842K 0.02% 580
2021
Q2
$1.97M Buy
134,661
+36,783
+38% +$537K 0.01% 691
2021
Q1
$2.44M Buy
97,878
+86,909
+792% +$2.17M 0.02% 573
2020
Q4
$299K Sell
10,969
-29,575
-73% -$806K ﹤0.01% 811
2020
Q3
$748K Buy
40,544
+23,314
+135% +$430K 0.01% 620
2020
Q2
$352K Buy
+17,230
New +$352K 0.01% 792
2020
Q1
Sell
-46,425
Closed -$659K 794
2019
Q4
$659K Sell
46,425
-83,503
-64% -$1.19M 0.01% 643
2019
Q3
$1.51M Buy
129,928
+63,622
+96% +$737K 0.02% 459
2019
Q2
$1.33M Buy
66,306
+8,237
+14% +$165K 0.02% 502
2019
Q1
$1.31M Buy
+58,069
New +$1.31M 0.02% 498